Beyond pregnancy: life-course management of gestational diabetes mellitus and its intergenerational impact: comprehensive review
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20262307Keywords:
Gestational diabetes mellitus, Intergenerational health, Life-course management, Maternal health, Offspring metabolic risk, Type 2 diabetesAbstract
Gestational diabetes mellitus (GDM) is a common metabolic disorder occurring during pregnancy and is increasingly recognized as a major public health concern due to its long-term implications for both mothers and their offspring. Although traditionally considered a temporary condition limited to pregnancy, growing evidence suggests that GDM is an early indicator of future metabolic disorders, including type 2 diabetes mellitus, metabolic syndrome and cardiovascular disease. This review aimed to examine the life-course management of gestational diabetes mellitus and explore its intergenerational impact on maternal and offspring health. A comprehensive literature review was conducted using electronic databases including PubMed, Scopus, Web of Science, CINAHL and Google Scholar. Relevant studies published between 2000 and 2024 were identified using keywords related to gestational diabetes, postpartum management, life-course approach and intergenerational health outcomes. The findings indicate that women with a history of GDM have a significantly higher risk of developing type 2 diabetes and other metabolic disorders later in life. In addition, exposure to maternal hyperglycemia during pregnancy increases the risk of obesity, insulin resistance and glucose intolerance in offspring, supporting the concept of developmental programming. Lifestyle interventions, breastfeeding, postpartum screening and integrated healthcare services were found to be effective strategies in reducing long-term risks. Adopting a life-course approach that includes early detection, continuous monitoring and preventive interventions is essential to break the cycle of intergenerational metabolic disease and improve long-term maternal and child health outcomes.
References
Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, et al. American Diabetes Association, Classification and diagnosis of diabetes: Standards of care in diabetes—2024. Diabetes Care. 2024;47(1):20-42.
Bellamy L, Casas JP, Hingorani AD, Williams D, Smith GD, Lawlor DA, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9.
Barker DJ, Eriksson JG, Forsén T, Osmond C, Kajantie E, Tuomilehto J, et al. The fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002;31(6):1235–9.
Hanson MA, Gluckman PD, Ma RCW, Matzen P, Biesma RG, Kluge H, et al. Early life opportunities for prevention of diabetes in low and middle income countries. BMC Public Health. 2012;12:1025.
Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
Kim C, Newton KM, Knopp RH, Kieffer EC, Ferrara A, Brown FM, et al. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–8.
Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER, Clausen TD, et al. Gestational diabetes mellitus and long-term consequences for mother and offspring. Nat Rev Endocrinol. 2016;12(7):397–407.
Tobias DK, Stuart JJ, Li S, Chavarro J, Rimm EB, Rich-Edwards JW, et al. Association of history of gestational diabetes with long-term cardiovascular disease risk in women. JAMA Intern Med. 2017;177(12):1735–42.
Feig DS, Berger H, Donovan L, Godbout A, Kader T, Keely E, et al. Diabetes and pregnancy clinical practice guidelines. Can J Diabetes. 2018;42(1):255–82.
World Health Organization, Roglic G, Colagiuri S, Alwan A, King H, Bennett PH, et al. Global report on diabetes. Geneva: WHO. 2016. Available at: https://www.who.int/publications. Accessed on 21 December 2025.
Zhu Y, Zhang C, Yeung EH, Shen Y, Qi L, Hu FB, et al. Long-term risk of type 2 diabetes after gestational diabetes. Lancet Diabetes Endocrinol. 2016;4(4):292–300.
Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–48.
Clausen TD, Mathiesen ER, Hansen T, Pedersen O, Jensen DM, Lauenborg J, et al. High prevalence of type 2 diabetes in adult offspring of women with gestational diabetes. Diabetes Care. 2008;31(2):340–6.
Gunderson EP, Hedderson MM, Chiang V, Crites Y, Walton D, Azevedo RA, et al. Lactation and progression to type 2 diabetes in women with gestational diabetes. Ann Intern Med. 2015;163(12):889–98.
International Diabetes Federation, Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, et al. Global and regional diabetes prevalence estimates. Diabetes Res Clin Pract. 2019;157:107843.
Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group, Higgins JPT, et al. Preferred reporting items for systematic reviews and meta-analyses (PRISMA). PLoS Med. 2009;6(7):1000097.
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;2:87.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews. BMJ. 2009;339:2700.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 statement. BMJ. 2021;372:71.
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. Newcastle–Ottawa scale for assessing the quality of nonrandomised studies. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed on 21 December 2025.
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2 critical appraisal tool for systematic reviews. BMJ. 2017;358:4008.
Carpenter MW, Coustan DR, Metzger BE, Dyer AR, Trimble ER, Chaovarindr U, et al. Gestational diabetes diagnostic criteria. Am J Obstet Gynecol. 2010;202(6):654–62.
Ferrara A, Hedderson MM, Albright CL, Ehrlich SF, Quesenberry CP, Peng T, et al. Lifestyle intervention to reduce type 2 diabetes risk in women with gestational diabetes. Diabetes Care. 2011;34(7):1519–25.
Tobias DK, Hu FB, Forman JP, Chavarro J, Zhang C, Manson JE, et al. Increased risk of hypertension after gestational diabetes. Diabetes Care. 2011;34(7):1582–4.
HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.
Lowe WL, Scholtens DM, Kuang A, Linder B, Lawrence JM, Lebenthal Y, et al. Hyperglycemia and adverse pregnancy outcome follow-up study. Diabetes Care. 2019;42(3):372–80.
Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, et al. The hyperglycemia and adverse pregnancy outcome study. Diabetes Care. 2012;35(4):780–6.
Yogev Y, Langer O, Xenakis EMJ, Rosenn B, Smith-Levitin M, Brustman L, et al. Glucose tolerance in pregnancy. Obstet Gynecol. 2004;104(4):771–7.
Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH, Shaw JE, et al. Global estimates of gestational diabetes prevalence. Diabetes Res Clin Pract. 2014;103(2):176–85.
Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG, et al. Gestational diabetes prevalence globally. BMJ Open. 2012;2:1001.
International Association of Diabetes and Pregnancy Study Groups, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. IADPSG recommendations. Diabetes Care. 2010;33(3):676–82.
Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL, et al. Progression to type 2 diabetes after gestational diabetes. BMJ. 2020;369:1361.
Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, et al. Prevention of diabetes in women with history of gestational diabetes. J Clin Endocrinol Metab. 2008;93(12):4774–9.
Retnakaran R, Shah BR, Shen S, Booth GL, Lipscombe LL, Tu JV, et al. Glucose intolerance and metabolic syndrome after gestational diabetes. Diabetes Care. 2009;32(5):903–7.
Shah BR, Retnakaran R, Booth GL, Lipscombe LL, Feig DS, Tu JV, et al. Increased cardiovascular disease risk after gestational diabetes. Circulation. 2008;118(25):2584–90.
Kozhimannil KB, Pereira MA, Harlow BL, DeSalvo KB, Pham-Kanter G, Liu H, et al. Gestational diabetes and postpartum depression risk. Am J Epidemiol. 2009;169(5):601–7.
Tovar A, Chasan-Taber L, Eggleston E, Oken E, Peterson KE, Gillman MW, et al. Postpartum screening after gestational diabetes. Prev Chronic Dis. 2011;8(6):124.
Bennett WL, Ennen CS, Carrese JA, Hill-Briggs F, Levine DM, Nicholson WK, et al. Barriers to postpartum follow-up after gestational diabetes. Am J Obstet Gynecol. 2011;205(5):1–7.
Kim C, McEwen LN, Kerr EA, Piette JD, Herman WH, Karter AJ, et al. Coordinated care improves postpartum diabetes screening. Diabetes Care. 2007;30(5):1312–6.
Catalano PM, Ehrenberg HM, Hauguel-De Mouzon S, HAPO Study Group, Lowe LP, Metzger BE, et al. Gestational diabetes and macrosomia. Obstet Gynecol. 2003;101(2):312–8.
Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ, et al. Childhood obesity risk after maternal gestational diabetes. Diabetes Care. 2007;30(9):2287–92.
Dabelea D, Hanson RL, Lindsay RS, Pettitt DJ, Imperatore G, Gabir MM, et al. Intrauterine exposure to diabetes and obesity. Diabetes. 2000;49(12):2208-11.
Pettitt DJ, Bennett PH, Hanson RL, Knowler WC, Baird HR, Aleck KA, et al. Offspring of mothers with diabetes risk. Diabetes Care. 1993;16(1):310–4.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Lifestyle intervention and diabetes prevention. N Engl J Med. 2002;346(6):393–403.
Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, et al. Diabetes prevention program outcomes. Lancet Diabetes Endocrinol. 2015;3(11):866–75.
Gunderson EP, Jacobs DR, Chiang V, Lewis CE, Tsai AL, Quesenberry CP, et al. Duration of lactation and diabetes risk. JAMA Intern Med. 2015;175(8):1373–81.
Ming WK, Mackillop LH, Farmer AJ, Loerup L, Bartlett K, Levy JC, et al. Digital health interventions for gestational diabetes. JMIR Mhealth Uhealth. 2016;4(2):32.
Mackillop LH, Hirst JE, Bartlett KJ, Birks JS, Clifton L, Farmer AJ, et al. Telemedicine in gestational diabetes. Diabetes Care. 2018;41(7):72–3.
McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P, et al. Gestational diabetes management. Lancet. 2019;393(10170):537–49.
Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Renzo GC, et al. FIGO initiative on gestational diabetes. Int J Gynecol Obstet. 2015;131(3):173–211.
Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B, et al. Glucose intolerance progression after GDM. Diabetes Care. 2010;33(8):1797–803.
Nicklas JM, Zera CA, England LJ, Rosner BA, Horton E, Seely EW, et al. Lifestyle challenges postpartum after GDM. Obstet Gynecol. 2011;118(5):1154–60.
Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH, et al. The pathophysiology of gestational diabetes. Int J Mol Sci. 2018;19(11):3342.
Gluckman PD, Hanson MA, Cooper C, Thornburg KL, Eriksson JG, et al. Effect of in utero conditions on adult health. N Engl J Med. 2008;359:61–73.
Tovar A, Chasan-Taber L, Eggleston E, Oken E, Gillman MW. Postpartum diabetes screening gaps. Prev Chronic Dis. 2011;8(6):124.
Kim C, Berger DK, Chamany S, Williams D. Postpartum diabetes prevention strategies. Curr Diab Rep. 2007;7(4):279–84.
Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH. Lifestyle prevention after gestational diabetes. J Clin Endocrinol Metab. 2008;93(12):4774–9.
Gunderson EP, Hedderson MM, Chiang V, Walton D, Azevedo RA, et al. Lactation and type 2 diabetes prevention. Ann Intern Med. 2015;163(12):889–98.
Mackillop LH, Bartlett K, Farmer AJ, Hirst JE, Levy JC, Tarassenko L, et al. Mobile health for gestational diabetes. JMIR Mhealth Uhealth. 2018;6(3):71.
McIntyre HD, Catalano PM, Zhang C, Desoye G, Mathiesen ER. Gestational diabetes management. Lancet. 2019;393:537–49.
World Health Organization, Roglic G, Norris SL, Colagiuri S, Boyko EJ. Screening and diagnosis of hyperglycemia in pregnancy. Geneva: WHO. 2013. Available at: https://www.who.int/publications. Accessed on 21 December 2025
Golden SH, Joseph JJ, Hill-Briggs F, Brancati FL. Social determinants of diabetes. Lancet Diabetes Endocrinol. 2018;6(10):781–92.
Hanson MA, Gluckman PD, Ma RCW, Matzen P. Life-course approach to diabetes prevention. BMC Public Health. 2012;12:1025.
Damm P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, Mathiesen ER. Long-term metabolic effects of GDM. Nat Rev Endocrinol. 2016;12(7):397–407.
Ma RCW, Popkin BM, Hanson MA. Gestational diabetes and intergenerational health risk. Nat Rev Endocrinol. 2020;16(10):1–12.
Downloads
Published
How to Cite
Issue
Section
